Verition Fund Management’s NEOPHOTONICS CORP NPTN Stock Holding History
Bought
Maintained
Sold
Other funds holding NPTN
AAM
PCM
PCMI
Verition Fund Management's NPTN Position: Q2 2022 in Review
Verition Fund Management sold out of NEOPHOTONICS CORP (NPTN) in Q2 2022, closing a stake of 34,016 shares — an estimated $517K sold.
Verition Fund Management first reported a position in NPTN in Q3 2013 and held it in 15 quarters. The position peaked at $1.29M in Q1 2019. 156 funds tracked by Wall St. Rank hold NPTN as of Q2 2022.
- Verition Fund Management reported no remaining NEOPHOTONICS CORP position as of Q2 2022 after selling out during the quarter.
- Verition Fund Management sold 34,016 NEOPHOTONICS CORP shares in Q2 2022, an estimated $517K.
- Verition Fund Management first reported a position in NEOPHOTONICS CORP in Q3 2013 and held it in 15 quarters.
- Verition Fund Management's NEOPHOTONICS CORP position peaked at $1.29M in Q1 2019.
- 156 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2022.
Based on Verition Fund Management's 13F filing for Q2 2022, filed 15 Aug 2022.